BPURQ.PK: Profile for BIOPURE CORP CL A

Biopure Corporation offers oxygen-carrying biological drugs called oxygen therapeutics. Oxygen therapeutics are intravenously administered to deliver oxygen to the bodys tissues. Its products include Hemopure, a human drug, for use in adult surgery patients who are acutely anemic and for eliminating, delaying, or reducing allogenic red blood cell transfusions in these patients; and Oxyglobin, a veterinary drug for the treatment of anemia in dogs. Hemopure is approved for sale in South Africa. The company focuses to market Hemopure to hospitals and pre-hospital environments; and sells Oxyglobin through distributors in the United States and Europe. The company was founded in 1984 and is headquartered in Cambridge, Massachusetts. On July 16, 2009, Biopure Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.

Key Statistics

COMPANY WEBSITES

Home Page

Search Yahoo! for:
More on Biopure Corp.

CORPORATE GOVERNANCE

Biopure Corp.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 61.2% of CGQ Universe companies and 38% of Pharmaceuticals, Biotechnology & Life Sciences companies.

Brought to you by Institutional Shareholder Services.

KEY EXECUTIVES

	Pay	Exercised
Mr. Zafiris G. Zafirelis , 64 Chairman, Chief Exec. Officer, Pres, Principal Financial Officer and Principal Accounting Officer	N/A	N/A
Mr. David N. Judelson , 80 Co-Founder, Vice-Chairman, Member of Audit Committee and Member of Compensation Committee	N/A	N/A
Ms. Jane Kober , 65 Sr. VP, Sec. and Gen. Counsel	N/A	N/A
Dr. A. Gerson Greenburg M.D., Ph.D., F.A.C.S., VP of Medical Affairs	N/A	N/A

Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.

View Insiders

Add to Portfolio

Set Alert

Email to a Friend

•

Annual Reports

•

Sector Analysis